| Visualizaciones | |
|---|---|
| Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-EGFR Therapy and Molecularly Selected by Circulating Tumor DNA Analyses: A Phase 2 Randomized Clinical Trial | 52 |
| enero 2024 | febrero 2024 | marzo 2024 | abril 2024 | mayo 2024 | junio 2024 | julio 2024 | |
|---|---|---|---|---|---|---|---|
| Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-EGFR Therapy and Molecularly Selected by Circulating Tumor DNA Analyses: A Phase 2 Randomized Clinical Trial | 0 | 17 | 0 | 7 | 5 | 13 | 10 |
| Visualizaciones | |
|---|---|
| artconlli_a2018_tabernero_josep_efficacy_Sym004.pdf | 7 |
| Visualizaciones | |
|---|---|
| Estados Unidos | 34 |
| China | 7 |
| Canadá | 2 |
| España | 1 |
| Visualizaciones | |
|---|---|
| Menlo Park | 24 |
| Shanghai | 6 |
| Oakland | 5 |
| San Diego | 4 |
| Ottawa | 2 |
| Barcelona | 1 |
| Guangzhou | 1 |
| Jackson | 1 |